Amarin Receives FDA Approval of VASCEPA® (icosapent ethyl) to Reduce Cardiovascular Risk | Amarin

Skip to main content

User account menu

Show — User account menu Hide — User account menu

Log in

Amarin

Submitted by amarin on Fri, 12/13/2019 - 22:35

ID Reference

18461

Search

Search

API search

Fulltext search

Title (indexed field):

Title (indexed field):

Title (indexed field): Home

Footer menu

Show — Footer menu Hide — Footer menu

Contact

Powered by Drupal